Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
Cardiovascular Research|February 2, 2006
Ligand triggers of classical preconditioning and postconditioningEric R Gross, Garrett J GrossExpert Opinion on Emerging Drugs|September 19, 2007
Pharmacologic therapeutics for cardiac reperfusion injuryEric R Gross, Garrett J GrossDrug Discovery Today. Disease Mechanisms|August 15, 2008
Ischemic Preconditioning And Myocardial Infarction: An Update and PerspectiveEric R Gross, Garrett J GrossDiabetes|December 29, 2006
Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3betaEric R Gross, Anna K Hsu, Garrett J GrossVascular Pharmacology|June 1, 2005
Opioid-induced preconditioning: recent advances and future perspectivesJason N Peart, Eric R Gross, Garrett J GrossThe Journal of Pharmacology and Experimental Therapeutics|March 3, 2004
Acute aspirin treatment abolishes, whereas acute ibuprofen treatment enhances morphine-induced cardioprotection: role of 12-lipoxygenaseEric R Gross, Anna K Hsu, Garrett J GrossCirculation Research|February 21, 2004
Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat heartsEric R Gross, Anna K Hsu, Garrett J GrossAnesthesia and Analgesia|October 22, 2009
Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusionEric R Gross, Anna K Hsu, Garrett J GrossJournal of Cardiovascular Pharmacology|April 13, 2004
Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarctionJason N Peart, Eric R Gross, Garrett J GrossAmerican Journal of Physiology. Heart and Circulatory Physiology|March 7, 2006
The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 betaEric R Gross, Anna K Hsu, Garrett J GrossPageof 15